image description

About the GCIC. Attraction Program Advisory Board

Frank Samuel

Frank Samuel

We mourn the loss of our colleague and friend,
GCIC Board member Frank Samuel

Biography

Frank Samuel was President of the Geauga Growth Partnership, Inc., a business organization focused on economic development in Geauga County (northeast Ohio). He was involved in biomedical technology and health care issues for many years in Washington, D.C., and the State of Ohio. He was Science and Technology Advisor to Ohio Governor Bob Taft from 2000 to 2007, where he was a principal architect of Ohio’s Third Frontier Project, one of the nation’s premier State initiatives to encourage economic development through support of applied research, technology commercialization and early stage capital creation. He was Corporate Director and former President of HIMA (now AdvaMed). He had served on the National Advisory Council of the California Health Benefits Review Program, served as Board chair at Providence Hospital (Washington, D.C.), as a member of Institute of Medicine advisory bodies on biomedical technology, and on the board of directors of several biomedical companies. His paper describing a venture capital strategy for the Great Lakes region was published by The Brookings Institution in 2010. He was a graduate of Hiram College and Harvard Law School.

Anthony J. Dennis, PhD

Anthony J. Dennis, PhD

Former President and CEO, BioOhio

Biography

Anthony J. Dennis, Ph.D., Former President and CEO of BioOhio. He is a microbiologist, entrepreneur, technology advocate and native Ohioan and became president of Edison BioTechnology Center, the predecessor organization to BioOhio, on January 1, 2002. Dr. Dennis is the third president in the organization’s 15-year history. He succeeded Frank Samuel Jr., who left the post to become science and technology advisor to Ohio Governor Bob Taft in June 2000. After receiving B.S. and Ph.D. degrees in microbiology from The Ohio State University, he began to work for Battelle in Columbus. He then served a two-year stint as president of IntraCel, a biotech company operating in Geneva, Switzerland. He returned to the U.S. to serve as vice president for research and development at Tastemaker (now Givaudan, a division of Roche).Dr. Dennis then co-founded Nutri-Logics, Inc., and following that, he was co-founding of another startup, BIO-NOVA, in Portland, before joining BioOhio.

Mark Low

Mark Low

Managing Director

Biography

Mark Low, Managing Director of the Global Cardiovascular Innovation Center as well as the Atrial Fibrillation Innovation Center, comes to these roles with a track record of building successful programs to introduce new biomedical products and modalities to new markets. He has managed all facets of product and market development spanning diagnostic and interventional cardiology, diagnostic and interventional pulmonology, interventional radiology, stroke treatment, image-guided surgery, drug delivery and oncology. He has served on the senior management teams of TomTec Imaging Systems, Image Guided Technologies, EKOS Corporation, and Sonus Pharmaceuticals, as well as business strategy consultant to numerous companies developing a wide array of cardiovascular devices. Prior to concentrating his focus on start-up ventures and early stage market development, Mark held trailblazing positions in marketing and business development for Hewlett-Packard’s Medical Products Group. Specializing in cardiovascular ultrasound, Mark managed high performance cardiovascular diagnostic systems, introducing numerous products to new market segments including office-based cardiology practice and interventional cardiology. He was responsible for developing new clinical applications including stress echocardiography, 3D echocardiography, and intravascular ultrasound. In conjunction with these programs Mark managed strategic relationships with various corporate partners, investors, universities, inventors, clinical investigators and manufacturers. Mark received a B.A. degree in Natural Science from Johns Hopkins University, an M.S. degree in Physiology from the Medical College of Wisconsin, and an M.S. degree in Technical Communication from Rensselaer Polytechnic Institute.

Matt Pollman, MD

Matt Pollman, MD

Consultant, Cardiovascular Therapeutic and Diagnostics

Biography

Matthew Pollman, consultant, has held a number of leadership positions in the development of cardiovascular therapeutics and diagnostics. He has most recently served as Medical Director, R&D, for Abbott Vascular. In this role, Dr. Pollman was the principal medical and scientific advisor for the R&D and Business Development organizations. Prior to this role, Dr. Pollman was the Director of New Ventures, Guidant Corporation where he led a multi-disciplinary in-house start-up incubator tasked with identifying, exploring and incubating through PhI/PhII clinical trials, novel therapeutic opportunities utilizing emerging device or combination product technologies. Dr. Pollman has also directed therapeutic/diagnostic target discovery and development efforts as Director of Cardiovascular Biology and Molecular Medicine for Millennium Pharmaceuticals. Dr. Pollman is a cardiologist and cardiovascular molecular biologist and has authored numerous peer-reviewed journal articles. He has served on the faculties of Harvard Medical School and Morehouse School of Medicine.

Thomas Sudow

Thomas Sudow

Director of Business Development, GCIC

Biography

Tom helps bioscience and medical device companies achieve growth in Northeast Ohio. Tom is a Vice President of Team NEO and the Director of Business Development for the Global Cardiovascular Innovation Center (GCIC), a research and product development consortium, led by the Cleveland Clinic, created to attract, expand and retain companies that develop new cardiovascular technologies. Tom has works with many international companies –most in the bioscience space – on establishing operations in the United States and in the acceleration of the their growth. He has organized seminar on doing business in the United States in Europe and the Middle East. Prior to joining the GCIC, Tom served as Executive Director of the Chamber of Commerce in Beachwood where he coordinated economic development efforts for the city. During his tenure, he helped more than 20 international companies establish their North America headquarters in Beachwood. Tom is committed to the Northeast Ohio community, having served as chair of the Northern Ohio Area Chambers of Commerce (NOACC). He is also a frequent guest columnist in publications such as Crain’s Cleveland Business, Inside Business and the Cleveland Jewish News. For his outstanding work, he has been recognized with awards from many economic development and community organizations.